Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Genome-wide interaction study of smoking and bladder cancer risk.

Figueroa JD, Han SS, Garcia-Closas M, Baris D, Jacobs EJ, Kogevinas M, Schwenn M, Malats N, Johnson A, Purdue MP, Caporaso N, Landi MT, Prokunina-Olsson L, Wang Z, Hutchinson A, Burdette L, Wheeler W, Vineis P, Siddiq A, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Bueno-de-Mesquita HB, Trichopoulos D, Ljungberg B, Clavel-Chapelon F, Weiderpass E, Krogh V, Dorronsoro M, Travis R, Tjønneland A, Brenan P, Chang-Claude J, Riboli E, Conti D, Gago-Dominguez M, Stern MC, Pike MC, Van Den Berg D, Yuan JM, Hohensee C, Rodabough R, Cancel-Tassin G, Roupret M, Comperat E, Chen C, De Vivo I, Giovannucci E, Hunter DJ, Kraft P, Lindstrom S, Carta A, Pavanello S, Arici C, Mastrangelo G, Karagas MR, Schned A, Armenti KR, Hosain GM, Haiman CA, Fraumeni JF Jr, Chanock SJ, Chatterjee N, Rothman N, Silverman DT.

Carcinogenesis. 2014 Aug;35(8):1737-44. doi: 10.1093/carcin/bgu064. Epub 2014 Mar 24.

2.

Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.

Schwender H, Selinski S, Blaszkewicz M, Marchan R, Ickstadt K, Golka K, Hengstler JG.

PLoS One. 2012;7(12):e51880. doi: 10.1371/journal.pone.0051880. Epub 2012 Dec 20. Erratum in: PLoS One. 2015;10(9):e0137937.

3.

A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility.

Zhang R, Chu M, Zhao Y, Wu C, Guo H, Shi Y, Dai J, Wei Y, Jin G, Ma H, Dong J, Yi H, Bai J, Gong J, Sun C, Zhu M, Wu T, Hu Z, Lin D, Shen H, Chen F.

Carcinogenesis. 2014 Jul;35(7):1528-35. doi: 10.1093/carcin/bgu076. Epub 2014 Mar 22.

4.

Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk.

de Maturana EL, Ye Y, Calle ML, Rothman N, Urrea V, Kogevinas M, Petrus S, Chanock SJ, Tardón A, García-Closas M, González-Neira A, Vellalta G, Carrato A, Navarro A, Lorente-Galdós B, Silverman DT, Real FX, Wu X, Malats N.

PLoS One. 2013 Dec 31;8(12):e83745. doi: 10.1371/journal.pone.0083745. eCollection 2013.

5.

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, Zhang Q, Millikan RE, Lerner S, Dinney CP, Spitz MR.

Am J Hum Genet. 2006 Mar;78(3):464-79. Epub 2006 Jan 31.

6.

GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, Johnson AT, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala SS, Chanock SJ, Cantor KP, Silverman DT, Rothman N.

Carcinogenesis. 2011 Feb;32(2):182-9. doi: 10.1093/carcin/bgq223. Epub 2010 Oct 29.

7.

Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility.

Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR.

Carcinogenesis. 2006 May;27(5):1030-7. Epub 2005 Nov 25.

PMID:
16311243
8.

Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.

Garcia-Closas M, Rothman N, Figueroa JD, Prokunina-Olsson L, Han SS, Baris D, Jacobs EJ, Malats N, De Vivo I, Albanes D, Purdue MP, Sharma S, Fu YP, Kogevinas M, Wang Z, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A, Gapstur SM, Thun M, Diver WR, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Hutchinson A, Burdett L, Jacobs KB, Yeager M, Fraumeni JF Jr, Chanock SJ, Silverman DT, Chatterjee N.

Cancer Res. 2013 Apr 1;73(7):2211-20. doi: 10.1158/0008-5472.CAN-12-2388. Epub 2013 Mar 27.

9.

An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.

Ji C, Liu Z, Chen H, Guo H, Liu C.

BMC Cancer. 2012 Aug 2;12:335. doi: 10.1186/1471-2407-12-335.

10.

N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.

Hosen MB, Islam J, Salam MA, Islam MF, Hawlader MZ, Kabir Y.

Asia Pac J Clin Oncol. 2015 Mar;11(1):78-84. doi: 10.1111/ajco.12291. Epub 2014 Nov 6.

PMID:
25376209
11.

Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.

Xing J, Dinney CP, Shete S, Huang M, Hildebrandt MA, Chen Z, Gu J.

Cancer. 2012 Jan 1;118(1):205-15. doi: 10.1002/cncr.26224. Epub 2011 Jun 20.

12.

High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility.

Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):84-91.

13.

Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.

Mhatre S, Wang Z, Nagrani R, Badwe R, Chiplunkar S, Mittal B, Yadav S, Zhang H, Chung CC, Patil P, Chanock S, Dikshit R, Chatterjee N, Rajaraman P.

Lancet Oncol. 2017 Apr;18(4):535-544. doi: 10.1016/S1470-2045(17)30167-5. Epub 2017 Mar 5.

PMID:
28274756
14.

Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer.

Wang M, Chu H, Lv Q, Wang L, Yuan L, Fu G, Tong N, Qin C, Yin C, Zhang Z, Xu J.

Int J Cancer. 2014 Dec 1;135(11):2653-60. doi: 10.1002/ijc.28898. Epub 2014 Apr 25.

15.

Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.

Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M, Esteller M, Fraga M, Rothman N, Malats N.

Lancet Oncol. 2008 Apr;9(4):359-66. doi: 10.1016/S1470-2045(08)70038-X. Epub 2008 Mar 12.

16.

GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.

Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, Coric V, Simic T.

Urol Oncol. 2013 Oct;31(7):1184-92. doi: 10.1016/j.urolonc.2011.08.005.

PMID:
24075358
17.

DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.

Gao Y, Hayes RB, Huang WY, Caporaso NE, Burdette L, Yeager M, Chanock SJ, Berndt SI.

Carcinogenesis. 2011 Jun;32(6):882-7. doi: 10.1093/carcin/bgr071. Epub 2011 Apr 18.

18.

Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.

Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P, Porru S.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1234-40.

19.

XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.

Stern MC, Johnson LR, Bell DA, Taylor JA.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1004-11.

20.

Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.

Rotunno M, Yu K, Lubin JH, Consonni D, Pesatori AC, Goldstein AM, Goldin LR, Wacholder S, Welch R, Burdette L, Chanock SJ, Bertazzi PA, Tucker MA, Caporaso NE, Chatterjee N, Bergen AW, Landi MT.

PLoS One. 2009 May 21;4(5):e5652. doi: 10.1371/journal.pone.0005652.

Supplemental Content

Support Center